Skip to main content

Want a detailed portfolio tracker?

Oragenics (OGEN) P/E (2020 - 2026)

Oragenics (OGEN) P/E from Sep 30, 2020 to Jul 21, 2026. The TTM Oragenics (OGEN) P/E is -0.25. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Oragenics (OGEN)

YearP/EChange
2026-0.25-29.67%
2025-0.35-89.18%
2024-3.23-94.56%
2023-59.39+32.84%
2022-44.71-112.75%
2021350.59+53.89%
2020227.82N/A

Comparison Oragenics (OGEN) P/E with competitors

Oragenics (OGEN) P/E is -0.25.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.69%
NBYStablecoin Development Corp0.00-101.75%
ENLVEnlivex Ltd0.07-130.43%
FGENFibroGen Inc0.24-197.64%
CHRSCoherus Biosciences Inc0.85-445.16%
FBIOFortress Biotech Inc0.95-486.04%
ORMPOramed Pharmaceuticals Inc1.50-711.40%
AGENAgenus Inc3.01-1324.23%
INVAInnoviva Inc3.15-1382.97%
VXRTVaxart Inc3.55-1543.94%
CRMDCorMedix Inc3.63-1575.95%
CVACCureVac N.V.4.45-1908.38%
GLPGGalapagos NV4.86-2076.46%
SRPTSarepta Therapeutics Inc4.88-2085.90%
ABEOAbeona Therapeutics Inc5.39-2291.49%
ABUSArbutus Biopharma Corp5.60-2376.15%
ZVRAZevra Therapeutics Inc5.89-2494.76%
SPROSpero Therapeutics Inc6.23-2633.56%
CGENCompugen Ltd6.31-2668.34%
RIGLRigel Pharmaceuticals6.87-2895.37%
SLXNSilexion Therapeutics Corp7.30-3067.85%
OMEROmeros Corporation9.26-3866.21%
AUPHAurinia Pharmaceuticals Inc9.58-3998.91%
PLXProtalix BioTherapeutics Inc10.89-4530.17%
ACADAcadia Pharmaceuticals Inc11.73-4870.86%
TBPHTheravance Biopharma Inc12.26-5087.92%
ADMAAdma Biologics Inc12.42-5151.38%
HRMYHarmony Biosciences Holdings Inc13.82-5721.70%
SABSSAB Biotherapeutics Inc14.14-5850.24%
NAGENiagen Bioscience Inc14.82-6127.63%
INCYIncyte Corp15.82-6536.21%
REGNRegeneron Pharmaceuticals Inc15.86-6550.08%
PBYIPuma Biotechnology Inc17.32-7143.59%
CPRXCatalyst Pharmaceuticals Inc17.44-7193.87%
EXELExelixis Inc17.54-7234.02%
TGTXTG Therapeutics Inc18.97-7814.91%
MDXGMimedx Group Inc20.55-8460.24%
XOMAXOMA Royalty Corp22.87-9405.09%
ARGXArgen X SE24.30-9984.07%
CTMXCytomX Therapeutics Inc24.82-10196.86%
XOMAOXOMA Royalty Corp25.34-10409.90%
HALOHalozyme Therapeutics Inc25.62-10523.35%
XOMAPXOMA Royalty Corp25.67-10542.22%
VRTXVertex Pharmaceuticals Inc27.99-11487.85%
RPRXRoyalty Pharma plc - Class A28.69-11769.67%
SLNOSoleno Therapeutics Inc29.02-11903.01%
ASNDAscendis Pharma A/S30.09-12338.36%
LGNDLigand Pharmaceuticals Inc - Class B37.91-15522.05%
APLSApellis Pharmaceuticals Inc39.02-15973.26%
BMRNBiomarin Pharmaceutical Inc42.21-17271.16%
KRYSKrystal Biotech Inc45.34-18545.06%
ONCBeiGene Ltd69.54-28388.04%
PHARPharming Group N.V.75.03-30619.32%
TECHBio-Techne Corp101.96-41575.20%
VCELVericel Corp109.92-44814.41%
ALNYAlnylam Pharmaceuticals Inc117.96-48086.50%
GMABGenmab140.29-57168.26%
TLXTelix Pharmaceuticals Ltd162.15-66061.43%
CORTCorcept Therapeutics Inc212.86-86687.37%